Literature DB >> 12514690

Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma.

Rita Gaspari1, Andrea Arcangeli, Sonia Mensi, Denise Schembri Wismayer, Tommaso Tartaglione, Daniela Antuzzi, Giorgio Conti, Rodolfo Proietti.   

Abstract

Ornithine transcarbamylase deficiency (OTCD) is an X-linked inherited disease and the most common inborn error in urea synthesis in human patients. In adult heterozygous patients, OTCD can be responsible for life-threatening hyperammonemic coma. We report the case of a 32-year-old woman admitted to our hospital with seizures after a recent high protein load. Her parents related a history of recurrent episodes of vomiting, meat refusal, lethargy, and convulsions since childhood, and measurement of plasma ammonemia levels was the key to early diagnosis of OTCD. We report the pathophysiologic characteristics, clinical features, clinical course, and differential diagnosis of OTCD and discuss the therapeutic options, including continuous venovenous hemodiafiltration and pharmacologic therapy for reduction of plasma ammonemia levels. A diagnosis of OTCD should be considered in adult nonhepatic patients with hyperammonemic coma, particularly if they have a history of protein avoidance and neurologic symptoms. Early recognition and appropriate treatment are critical to avoid severe brain damage and death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514690     DOI: 10.1067/mem.2003.6

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  9 in total

Review 1.  Brain imaging in urea cycle disorders.

Authors:  Andrea Gropman
Journal:  Mol Genet Metab       Date:  2010-02-13       Impact factor: 4.797

Review 2.  Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.

Authors:  Ileana Pacheco-Colón; Stanley Fricke; John VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

3.  [Patients with ornithine transcarbamylase deficiency. Anaesthesiological and intensive care management].

Authors:  J Schmidt; M Schroth; A Irouschek; T Birkholz; M Kurzai; S Kröber; M Meisner; S Albrecht
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

4.  Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male.

Authors:  Ophir D Klein; Dana R Kostiner; Kara Weisiger; Ellen Moffatt; Neal Lindeman; Stephen Goodman; Mendel Tuchman; Seymour Packman
Journal:  Hepatol Int       Date:  2008-05-07       Impact factor: 6.047

Review 5.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

6.  Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency.

Authors:  Jacob F Collen; Nealanjon P Das; Jonathan M Koff; Robert T Neff; Kevin C Abbott
Journal:  Appl Clin Genet       Date:  2008-07-24

Review 7.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

8.  [Ornithine transcarbamylase deficiency in adolescence and adulthood: first manifestation with life-threatening decompensation].

Authors:  M Bürle; H Mende; U Plum; M Bluthardt; M Walka; G Geldner
Journal:  Anaesthesist       Date:  2009-06       Impact factor: 1.041

Review 9.  Severe hyperammonemia from intense skeletal muscle activity: A rare case report and literature review.

Authors:  Vikas Taneja; Haneesh Jasuja
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.